Skip to content

ARTBIO vs Endocyte

ARTBIO logo

ARTBIO

Channeling Energy. Changing Lives

74 employees · est. 2021 · Cambridge, United States

VS
Endocyte logo

Endocyte

16 employees · est. 1996 · West Lafayette, United State...

Endocyte is the older company (2021 vs 1996); ARTBIO is the larger of the two.

Side-by-Side Comparison

ARTBIO Endocyte
Founded
2021 1996 older
Headquarters
Cambridge, United States West Lafayette, United States
Employees
74 larger 16
Industry
Biotechnology, Health Care, Medical Devices Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series B Debt Financing
Total Funding
$245.00M $114.35M
Funding Rounds
3 7
Services
Development of Alpha Radioligand Therapies, Clinical Research and Trials, Manufacturing Ecosystem for Therapy Solutions Not tracked yet
Target Customers
Cancer Patients, Oncologists, Healthcare Providers Not tracked yet
Taxonomy
Alpha Radioligand TherapiesRadiopharmaceuticalsClinical-stageCancer CarePrecision MedicinePb-212 Isotope Technology +6 BiopharmaceuticalCancer TreatmentTargeted TherapiesDrug Conjugation TechnologyPSMA-targeted Radioligand TherapyMCRPC +4
Website
artbio.com endocyte.com
ARTBIO logo

About ARTBIO

ARTBIO, founded in 2021 and based in the United States, is pioneering a paradigm shift in cancer treatment. Their focus on developing Alpha Radioligand Therapies (ARTs) leverages unique Pb-212 isotope technology, aiming to offer transformative solutions in oncology. The company’s mantra, “Channeling...

Endocyte logo

About Endocyte

Endocyte is a biopharmaceutical company and a leader in developing targeted therapies for the personalized treatment of cancer. The company's drug conjugation technology targets therapeutics and companion imaging agents specifically to the site of diseased cells. Endocyte's lead program is a prostat...

Also comparing in this category

Comparing more than these two?

Get ARTBIO, Endocyte and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does ARTBIO compare?

A PDF of ARTBIO and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

ARTBIO was founded in 2021, based in Cambridge, United States, with 74 employees. ARTBIO, founded in 2021 and based in the United States, is pioneering a paradigm shift in cancer treatment. Their focus on developing Alpha Radioligand Therapies (ARTs) leverages unique Pb-212 isotope. Endocyte was founded in 1996, based in West Lafayette, United States, with 16 employees. Endocyte is a biopharmaceutical company and a leader in developing targeted therapies for the personalized treatment of cancer. The company's drug conjugation technology targets therapeutics and compa.
ARTBIO has raised $245.00M and Endocyte $114.35M. Latest stage: ARTBIO Series B, Endocyte Debt Financing.
Both work in Biotechnology, Health Care and Pharmaceutical and list precision medicine and oncology among their focus areas.

Compare ARTBIO with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ARTBIO on 9 Jun 2026, and Endocyte on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout